Trial intelligence / Profile preview

Vitamin D and GI Mucosa FoxP3+ T Cells (ADPP Step 3)

NCT01538485Phase 4Completed

Sponsor
Medical University of Graz
Start
Jan 2012
Primary completion
Aug 2012
Countries
1
01

Overview

Phase 4, open-label trial of vitamin d in type 1 diabetes mellitus (T1D), sponsored by Medical University of Graz. Primary endpoint: Regulatory FOXP3+ T cells in the gastrointestinal mucosa at 2 months. Started Jan 2012; status: completed.

02

Drugs

vitamin d
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT01538485.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01538485.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call